Global Tuberculosis Symposium

DATE: Tuesday, 28 October 2014
TIME:  09:00 - 17:00
ROOM:  112

The Global Tuberculosis Symposium is organised by the World Health Organization (WHO) and is open to all delegates; no badge is required to access the meeting room.

Background: For a world free of TB, out-of-the-box action is needed that builds on the fundamentals of quality TB prevention, care and control.

In May 2014, the World Health Assembly approved the World Health Organization's Post-2015 Global TB Strategy, which aims to end the global TB epidemic by 2035 with an associated 95% decline in TB deaths, a 90% decline in TB incidence and the elimination of catastrophic costs for TB-affected households.  Core actions of the strategy are framed under three pillars:

1. Integrated patient-centred care and prevention

2. Bold policies and supportive systems

3. Intensified research and innovation.

The strategy was developed through broad-based consultations with countries, partner organisations, civil society and academic experts.  Among these consultations were two previous Union World Conference on Lung Health symposia, which focused  in 2012 on framing the overall targets and strategic framework and, in 2013, on elaborating on the elements of its third pillar on research.

Building on these events, the Global TB Symposium in 2014 proposes to address how the strategy now can be taken forward through country adaptation. The strategy will fail if it is formulaically applied in all settings.  Defining the right course for adaptation in 2015, and initiating a rapid pace for implementation from early 2016, will be essential.   Business as usual won't suffice.   Out-of-the-box actions being taken by some governments, partners and communities today demonstrate that the unusual is possible.

Objectives of the symposium:

1. To offer participants an overview of the epidemiologic, programmatic and political context that set the baseline for implementing the new global TB strategy;

2. To provide examples of locally-specific applications using the innovative elements of the strategy and global support.

Agenda  

 

I.  Introduction

9h00 – 9h30

Welcome, Introduction and Remembrance

Inaugural Remarks

Mr José Luis Castro, The Union,                  Dr Mario Raviglione, WHO

Dr Harsh Vardhan, Minister of Health, India

     9:30 – 9:35 Moving out-of-the-Box: Introduction

Ms Diana Weil, WHO

9:35 – 10:00

Global TB care and control: current progress

Dr Katherine Floyd, WHO

10:00 – 10:25

Pursuing the global TB strategy within  post-2015 global health diplomacy

Ambassador Eric Goosby,  University of California, San Francisco, UCSF

10:25 – 10:30

The role of Parliamentarians in driving progress towards 2035 targets

Rt. Hon. Nick Herbert, Member of Parliament, United Kingdom

10:30 – 10:40

Questions/Comments

 

10:40 – 11:10

Coffee Break

 

11:10 – 11:15

II. Adopting and adapting the strategy

Co-chairs: Dr Catherina van Weezenbeek, Royal Netherlands TB Foundation                                                                                                                                         Dr Ya Diul Mukadi, US Agency for International Development

               

11:15 – 11:35

Setting the course to 2035: a national perspective

Dr Viet Nhung Nguyen, Ministry of Health, Vietnam

11:35 – 11:50

A framework towards TB elimination for low-incidence countries

Dr Knut Lonnroth, WHO

11:50 – 12:05

 Framing a response that fits the epidemic: epidemiology and engagement

Dr Ibrahim Abubakar, Dr Sarah Anderson,

Public Health England   

12:05 – 12:30

Questions/Comments

 

12:30 – 13:30

Lunch

 

13:30 – 13:35

III.  Pillar 1: Integrated, patient-centred care & prevention

Co-Chairs: Lucy Chesire, TB Advocacy Consortium

                  Dr  Malgosia Grzemska, WHO

13:35 – 13:50

Getting to universal rapid diagnosis & drug-susceptibility testing:  what will it take?

Catharina Boehme, Foundation for Innovative New Diagnostics, FIND

13:50 – 14:05

Patient-centred models of care: pursuing the mandate

Ernesto Jaramillo, WHO

Tajikistan National TB Programme & Médecins Sans Frontières

     14:05 – 14:25

Moving on preventive therapy

Dr Haileyesus Getahun, WHO

     14:25 - 14:50

Questions/Comments

 

 

14:50 -14:55

 

IV: Pillar 2:  Bold policies and supportive systems

Co-Chairs: Dr Michael Johnson, The Global Fund

                   Dr Draurio Barreira, Ministry of Health, Brazil

15:00 - 15:15

Removing catastrophic patient costs with universal health coverage financing and social protection

Dr Viorel Soltan, Center for Health Policies and Studies, Moldova

15:15 – 15:30

The carrot and the stick:  policy & regulation to reduce antimicrobial resistance

Dr Lyn Vianzon, Ministry of Health, Philippines

15:30  - 15:45

Questions/Comments

 

15:45 - 16:10

Coffee break

 

 

16:10 – 16:15

V. Pillar 3:  Intensified research & innovation

Co-Chairs: Michael Kimerling, Bill & Melinda Gates Foundation

                   Christian Lienhardt, WHO

16:15 – 16:30

Panel: rolling out a policy implementation package for new TB drugs and regimens

Dr Gavin Churchyard, Aurum Institute,      Dr Norbert Djeka, South Africa Department of Health

Dalene von Delft, TB PROOF

16:30 – 16:45

Collaboration for effective TB drug regimen trials

Dr I.D. Rusen, The Union

16:45 – 17:00

Questions/Comments

 

17:00 – 17:05

VI.  Developing the global plan to Stop TB,  2016-2020: introduction

Chair: Dr Paula Fujiwara, The Union and Chair of The Stop TB Partnership Task Force on the Global Plan to Stop TB

17:05 – 17:35

The importance of the Global Plan in achieving the post-2015 strategy

Aaron Motsoaledi, Minister of Health, South Africa

17:35 – 17:45

Questions/Comments

 

17:45 – 17:55

VII. Kochon Prize Award Ceremony

Kochon Foundation, Stop TB Partnership

                                                                                           Chairman: Kim Doo-Hyun, Kochon Prize

                                                                                           Foundation

                                                                                           Lucica Ditiu, Stop TB Partnership

17:55 – 18:00

VIII. Concluding remarks

Ambassador Eric Goosby, UCSF

Mario Raviglione, WHO